This systematic review and meta-analysis clarifies the major and minor risk factors associated with developing early-onset food allergy to inform optimal prevention clinical practice, policy, and ...

ELLICOTT CITY, MD, UNITED STATES, March 19, 2026 /EINPresswire.com/ — The Hereditary Neuropathy Foundation (HNF) will host its largest Charcot-Marie-Tooth (CMT) Summit + Health and Wellness Retreat at ...

First and only FDA-approved therapy for the treatment of acquired hypothalamic obesity, a rare disease characterized by accelerated and ...

Chief Executive Officer — Dr. Sergio Traversa Chief Medical Officer, Oncology — Dr. Raj S. Pruthi Chief Financial Officer — Maged S. Shenouda With me on today's call are Relmada Therapeutics, Inc.'s ...

Donanemab and lecanemab were licensed for use in the UK in 2024 but were not made available on the NHS after Nice deemed their benefits “too small” to justify the cost ...

A new form of CAR T kills leukemia, multiple myeloma, and sarcoma in mice, opening the door to a future off-the-shelf cancer treatment without chemotherapy.

Good day, and thank you for standing by. Welcome to the Taysha Gene Therapies Full Year 2025 Financial Results Conference Call. [Operator Instructions] Please be advised that today's conference is ...

The big release this week is Project Hail Mary, and I've reviewed it below. But there are plenty of other screenings worth your while, including of restoration of Roberto Rossellini's Stromboli at the ...

James E. Dentzer said, "we sold what was remaining to Oberland to clean it all up. We are now completely independent of the Erivedge stream," emphasizing an operational pivot from legacy assets.

Discover how CRISPR genome editing is revolutionizing medicine. Learn the science of Cas9, current clinical trials, and the future of gene editing.

What has long been interpreted as permanent and irreversible vascular damage may not be exclusively so. In people with Down syndrome—one of the most robust populations for studying Alzheimer's disease ...